{
  "thread": {
    "uuid": "649470851c64fcf6e13b43b679e2cc81c183a474",
    "url": "https://www.gurufocus.com/news/2760774/study-links-shingles-vaccine-to-lower-dementia-risk-implications-for-gsk-gsk-and-merck-mrk",
    "site_full": "www.gurufocus.com",
    "site": "gurufocus.com",
    "site_section": "https://www.gurufocus.com/rss.php",
    "site_categories": [
      "investing",
      "financial_news",
      "finance"
    ],
    "section_title": "GuruFocus New Articles",
    "site_title": "GuruFocus | Stock Market Research, Data and Tools",
    "title": "Study Links Shingles Vaccine to Lower Dementia Risk; Implications for GSK (GSK) and Merck (MRK)",
    "title_full": "Study Links Shingles Vaccine to Lower Dementia Risk; Implications for GSK (GSK) and Merck (MRK)",
    "published": "2025-04-03T00:32:09.996+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "https://static.gurufocus.com/logos/0C000007W1.png?20",
    "performance_score": 0,
    "domain_rank": 8490,
    "domain_rank_updated": "2025-04-01T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "649470851c64fcf6e13b43b679e2cc81c183a474",
  "url": "https://www.gurufocus.com/news/2760774/study-links-shingles-vaccine-to-lower-dementia-risk-implications-for-gsk-gsk-and-merck-mrk",
  "ord_in_thread": 0,
  "author": "@gurufocus",
  "published": "2025-04-03T00:32:09.996+03:00",
  "title": "Study Links Shingles Vaccine to Lower Dementia Risk; Implications for GSK (GSK) and Merck (MRK)",
  "text": "Key Insights:\n- Analysis shows a promising link between shingles vaccination and reduced dementia risk.\n- GSK's Shingrix vaccine gains favor over Merck's Zostavax due to higher efficacy.\n- Analysts project a potential upside for GSK PLC from both price targets and GF Value estimates.\nA recent study highlights a compelling connection between shingles vaccination and brain health, uncovering a 20% reduction in dementia diagnosis among the elderly over a seven-year period. This extensive analysis, conducted using health records of over 282,500 individuals in Wales, underscores the importance of mitigating viral infections for cognitive health. Currently, GSK's (GSK, Financial) Shingrix leads the way as the preferred vaccine due to its superior efficacy, despite an increased incidence of side effects when compared to Merck's (MRK) older Zostavax.\nWall Street Analysts Forecast\nAccording to projections from six financial analysts, GSK PLC (GSK, Financial) is set for an average price target of $39.54 over the next year, with estimates ranging from a high of $45.00 to a low of $35.50. This average target price indicates an anticipated upside of 5.05% from its current trading price of $37.64. For a more in-depth analysis, visit the GSK PLC (GSK) Forecast page.\nIn terms of stock recommendations, the consensus among eight brokerage firms rates GSK PLC (GSK, Financial) at an average recommendation of 2.9, categorizing it as a \"Hold.\" The recommendation scale where the lowest rating of 1 signifies a \"Strong Buy\" and 5 indicates a \"Sell,\" provides a nuanced guide for investors.\nFurther value is gleaned from GuruFocus' analysis, which estimates the one-year GF Value for GSK PLC (GSK, Financial) at $42.31. This reflects a projected upside of 12.41% from the current market price of $37.64. The GF Value represents GuruFocus' approach to determining a stock's fair trading value, integrating historical trading multiples, past business growth, and future business performance projections. For further insights, review the complete data on the GSK PLC (GSK) Summary page.",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "positive",
  "categories": [
    "Health",
    "Science and Technology"
  ],
  "topics": [
    "Health->medical test",
    "Health->health treatment and procedure",
    "Health->vaccine",
    "Science and Technology->biomedical science",
    "Science and Technology->social sciences",
    "Science and Technology->medical research"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": false,
  "webz_reporter": false,
  "external_links": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "bias": null
  },
  "rating": null,
  "crawled": "2025-04-03T00:32:09.996+03:00",
  "updated": "2025-04-03T00:32:09.996+03:00"
}